Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)
Clinical trial NCT02076178 · COMPLETED
Trial details
- NCT number
- NCT02076178
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-27
- Primary completion
- 2015-05-15
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.